SPOT-MAS Multi-Cancer Screening (Detection of 10 Cancer Types)

Early Detection Increases the Chance of Survival

Early cancer detection significantly improves treatment outcomes. When cancer is detected at an early stage, the survival rate can increase to 90–95%. However, more than 70% of cancer patients are diagnosed at a late stage, when treatment becomes more complex and costly, placing a heavy financial burden on patients and their families.

According to the World Health Organization (WHO), cancer-related mortality is projected to increase by 45% by the year 2030. Early detection enables timely treatment, improves survival rates, and helps reduce overall healthcare costs.

SPOT-MAS Multi-Cancer Early Detection

SPOT-MAS is an advanced Multi-Cancer Early Detection (MCED) technology that identifies cancer-derived DNA fragments released into the bloodstream, known as Circulating Tumor DNA (ctDNA). The test utilizes Next-Generation Sequencing (NGS) technology to detect multiple cancers simultaneously, even at early stages, in individuals with no symptoms.

• Single blood draw

• Non-invasive

• Results available within 30 working days

Detect 10 Types of Cancer in a Single Test

(SPOT-MAS – Multi-Cancer Screening)

1. Liver Cancer

2. Lung Cancer

3. Breast Cancer

4. Colorectal Cancer

5. Stomach (Gastric) Cancer

6. Ovarian Cancer

7. Pancreatic Cancer

8. Esophageal Cancer

9. Uterine Cancer

10. Bile Duct Cancer (Cholangiocarcinoma)

Key Benefits

• Simple, fast, and minimally invasive with only one blood sample

• Screens for multiple cancers simultaneously

• No invasive procedures required, such as tissue biopsy or surgery

• High accuracy with 95.9% specificity and 73.9% sensitivity*

*Performance data provided by Gene Solutions

Who Should Consider This Test?

• Individuals aged 40 years and above, as recommended by WHO for cancer screening

• Smokers or individuals who consume alcohol regularly

• Individuals living in areas with high PM2.5 air pollution

• Individuals with a family history of cancer (genetic cancer risk)

• Individuals aged 18 years and above who wish to proactively screen for cancer at an early stage

Additional Health Recommendations

Regular health check-ups are strongly recommended, including breast cancer screening, cervical cancer screening, and annual health examinations tailored to age and individual risk factors. Early detection of abnormalities allows for timely and effective treatment.

Terms and Conditions

1. This service is available exclusively at Phyathai Sriracha Hospital.

2. The promotional price includes physician fees and hospital service charges.

3. The purchased package can be used within 3 months from the date of payment.

4. Advance appointment is required prior to the test.

5. This promotion cannot be exchanged, refunded, or redeemed for cash. No refunds under any circumstances.

6. The hospital reserves the right to change the terms and conditions without prior notice